GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Omnicell Inc (STU:OC9) » Definitions » Additional Paid-In Capital

Omnicell (STU:OC9) Additional Paid-In Capital : €1,048 Mil(As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Omnicell Additional Paid-In Capital?


Omnicell's quarterly additional paid-in capital declined from Sep. 2023 (€1,040 Mil) to Dec. 2023 (€1,029 Mil) but then increased from Dec. 2023 (€1,029 Mil) to Mar. 2024 (€1,048 Mil).

Omnicell's annual additional paid-in capital increased from Dec. 2021 (€907 Mil) to Dec. 2022 (€988 Mil) and increased from Dec. 2022 (€988 Mil) to Dec. 2023 (€1,029 Mil).


Omnicell Additional Paid-In Capital Historical Data

The historical data trend for Omnicell's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omnicell Additional Paid-In Capital Chart

Omnicell Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 702.84 756.54 906.75 988.14 1,029.14

Omnicell Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,001.89 1,004.99 1,040.16 1,029.14 1,047.89

Omnicell Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Omnicell Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Omnicell's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Omnicell (STU:OC9) Business Description

Traded in Other Exchanges
Address
2625 Augustine Drive, Suite 301, Santa Clara, CA, USA, 95054
Omnicell Inc provides automation and business analytics software for healthcare providers. The automation and analytics segment manufactures medication dispensing systems, pharmacy inventory management systems, and related software. The medication adherence segment sells products like consumable medication blister cards and packaging equipment to help administer medication outside of a hospital setting. Omnicell generates the vast majority of its revenue in the United States.

Omnicell (STU:OC9) Headlines

No Headlines